Methods for detecting rheumatoid arthritis

JP2026169104APending Publication Date: 2026-10-16PROTEOBRIDGE CORP
0 Cites 0 Cited by

Patent Information

Application Number
JP2025069019
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-04
Filing Date
2025-04-18
Publication Date
2026-10-16

AI Technical Summary

Benefits of technology

【0007】 本発明によれば、関節リウマチの検出または診断を簡便かつ的確に実施できる点で有利である。本発明によればまた、従来のバイオマーカーでは検出または診断が難しい対象に対しても関節リウマチを検出することができるとともに、関節リウマチの検出において従来のバイオマーカーよりも精度が高い点でも有利である。

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

To provide a novel detection method for rheumatoid arthritis. [Solution] The present invention provides a method for detecting rheumatoid arthritis, comprising the step of determining the presence of rheumatoid arthritis using the amount or concentration of autoantibodies against citrullinated proteins (citrullinated protein autoantibodies) in a target biological sample as an indicator, wherein the citrullinated protein autoantibodies are (1) citrullinated RBMXL2 autoantibodies and / or (2) citrullinated CDKN1C autoantibodies. The present invention is advantageous in that it allows for the simple and accurate detection of rheumatoid arthritis. Furthermore, the present invention is advantageous in that it can detect rheumatoid arthritis even in subjects that are difficult to detect with conventional biomarkers, and in that it has higher accuracy than conventional biomarkers in detecting rheumatoid arthritis.
Need to check novelty before this filing date? Find Prior Art